1-Apr-2026 7:00 AM CST - Business Wire Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026 Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2026 before the market opens on Thursday, April 23, 2026, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the Investors section of our website, www.thermofish
24-Mar-2026 11:17 AM CST - Yahoo Finance Thermo Fisher Scientific (TMO) Partners With AIM ImmunoTech on Phase 3 Cancer Trial Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the 10 Best Diagnostics and Research Stocks to Buy According to Analysts. On March 2, 2026, AIM ImmunoTech announced entering into an agreement with the PPD clinical research business of Thermo Fisher Scientific (TMO) to design a pivotal Phase 3 clinical trial for Ampligen.
2-Mar-2026 4:00 PM CST - Benzinga Here's How Much $100 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth Today Thermo Fisher Scientific (NYSE: TMO) has outperformed the market over the past 20 years by 5.51% on an annualized basis producing an average annual return of 14.29%. Currently, Thermo Fisher Scientific has a market capitalization of $191.87 billion.
2-Mar-2026 11:29 AM CST - Seeking Alpha Thermo Fisher Scientific: Recovery In Life Sciences Solutions Thermo Fisher Scientific is reiterated as a 'buy' with a fair value estimate of $619 per share, reflecting confidence in its recovery and strategic positioning. TMO's acquisition of Clario Holdings for $8.875 billion is expected to enhance recurring revenue, accelerate organic growth, and support future AI-driven clinical trial solutions.
Latest TMO Trades by Congress Members
31-OCT-2025 - Lisa McClain, MI (District 9) sold between $1,001 and $15,000.
1-Apr-2026 7:00 AM CST - Business Wire Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026 Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2026 before the market opens on Thursday, April 23, 2026, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the Investors section of our website, www.thermofish
24-Mar-2026 11:17 AM CST - Yahoo Finance Thermo Fisher Scientific (TMO) Partners With AIM ImmunoTech on Phase 3 Cancer Trial Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the 10 Best Diagnostics and Research Stocks to Buy According to Analysts. On March 2, 2026, AIM ImmunoTech announced entering into an agreement with the PPD clinical research business of Thermo Fisher Scientific (TMO) to design a pivotal Phase 3 clinical trial for Ampligen.
2-Mar-2026 4:00 PM CST - Benzinga Here's How Much $100 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth Today Thermo Fisher Scientific (NYSE: TMO) has outperformed the market over the past 20 years by 5.51% on an annualized basis producing an average annual return of 14.29%. Currently, Thermo Fisher Scientific has a market capitalization of $191.87 billion.
2-Mar-2026 11:29 AM CST - Seeking Alpha Thermo Fisher Scientific: Recovery In Life Sciences Solutions Thermo Fisher Scientific is reiterated as a 'buy' with a fair value estimate of $619 per share, reflecting confidence in its recovery and strategic positioning. TMO's acquisition of Clario Holdings for $8.875 billion is expected to enhance recurring revenue, accelerate organic growth, and support future AI-driven clinical trial solutions.
